In vivo administration of glucosamine inhibited phosphatidylinositol 3-kinase activity without affecting tyrosine phosphorylation of the insulin receptor or insulin receptor substrate in rat adipocytes

Miki, T.; Sakaue, M.; Kasuga, M.

Kobe Journal of Medical Sciences 48(3-4): 105-114

2002


ISSN/ISBN: 0023-2513
PMID: 12502902
Document Number: 545543
We examined insulin signalling in rat epididymal adipocytes which developed insulin resistance by the in vivo infusion of glucosamine. Insulin-stimulated 2-deoxyglucose uptake into the adipocytes isolated from rats which were infused glucosamine for 4 h was diminished by 26%. To analyse insulin signalling in adipocytes, the epididymal fat tissues were harvested 5 min after insulin administration (10 U/kg), which was administered immediately after glucosamine infusion. Glucosamine had no effect on the insulin-stimulated tyrosine phosphorylation of the insulin receptor and insulin receptor substrate (IRS)-1. Glucosamine infusion decreased insulin-stimulated phosphatidylinositol (PI) 3-kinase activity by 66%. Glucosamine infusion also inhibited insulin-stimulated PI 3-kinase activity associated with IRS-1, IRS-2 and IRS-3 by 30, 43 and 44%, respectively. There was no difference in the association of the 85kDa subunit of PI 3-kinase with the IRS-1 and IRS-2 protein. PI 3-kinase activity in adipocytes from rats treated with glucosamine that were administered platelet-derived growth factor (3 micro g/kg) for 5 min was also reduced by 39%. When we measured the kinase activity of protein kinase C (PKC) lambda , which is the downstream effector of PI 3-kinase in isolated adipocytes, we found that glucosamine inhibited insulin stimulated PKC lambda kinase activity by 33%. These results suggest that glucosamine infusion contributes to the development of insulin resistance by mainly modulating the PI 3-kinase molecules.

Document emailed within 1 workday
Secure & encrypted payments